Sign up to save your podcasts
Or
Share Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Resilience in Neurodegeneration: Prilenia’s Journey in Huntington’s Disease Drug Development
In this episode of The Life Science Insider, Kieran Canisius speaks with Limor Ben Har, COO of Prilenia Therapeutics, about what it takes to lead through complexity. Together they unpack the true meaning of biotech resilience - how a science-driven, patient-focused team turned unexpected data into a strategic partnership and renewed momentum.
Limor offers candid insight into neurodegenerative development, market expectations, and the power of staying mission-aligned through it all.
🎧 Subscribe to The Life Science Insider and follow Seuss+ for more behind-the-scenes biotech leadership stories.
View all episodes
By Seuss+In this episode of The Life Science Insider, Kieran Canisius speaks with Limor Ben Har, COO of Prilenia Therapeutics, about what it takes to lead through complexity. Together they unpack the true meaning of biotech resilience - how a science-driven, patient-focused team turned unexpected data into a strategic partnership and renewed momentum.
Limor offers candid insight into neurodegenerative development, market expectations, and the power of staying mission-aligned through it all.
🎧 Subscribe to The Life Science Insider and follow Seuss+ for more behind-the-scenes biotech leadership stories.